(Press-News.org)
The hormone glucose-dependent insulinotropic polypeptide (GIP) is considered obesogenic. In contrast, GIP receptor agonists (GIPRAs) have shown reduced feeding and body weight in an obese mouse model. Therefore, the precise effects exerted by GIP and GIPRAs remain elusive. Recently, researchers demonstrated acute feeding inhibition and lowered body weight in mice with diet-induced obesity treated with GIPFA-085, a long-acting GIPRA. Their findings provide a scientific basis for GIP therapy for diabetes and obesity.
Obesity, type 2 diabetes, and their associated comorbidities contribute to millions of deaths across the globe every year. While lifestyle interventions can decrease the progression of these diseases, there is a distinct lack of proven and safe treatments for obesity. Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone released by the small intestine that stimulates insulin secretion upon eating food. While some researchers have shown that GIP promotes obesity, others have presented contradictory evidence that GIP receptor agonists (GIPRAs), which essentially have the same function as GIP, prevent the disease. Therefore, there is a need to clarify the mechanisms and effects of GIP and GIPRA on body weight and feeding.
Recently, researchers from Japan were able to demonstrate that GIPFA-085, a long-acting GIPRA, acutely inhibited feeding and lowered the body weight of diet-induced obese (DIO) mice in a sustained manner. Dr. Toshihiko Yada from Kansai Electric Power Medical Research Institute and Gifu University Graduate School of Medicine led the research team that made this important discovery, which has been published in Diabetes, Obesity and Metabolism. The team also consisted of Dr. Wanxin Han and Dr. Daisuke Yabe from Gifu University's Graduate School of Medicine and Center for One Medicine Innovative Translational Research and Dr. Yutaka Seino from Kansai Electric Power Hospital.
Says Dr. Yada, who is the corresponding author of the study, “GIP has been considered obesogenic by some researchers. In contrast, GIPRAs, alone and in combination with glucagon-like peptide-1 (GLP-1) receptor agonists, reportedly reduce feeding and body weight in diet-induced obese (DIO) mice. In this regard, this study aimed to clarify the effects of GIPRA on feeding and body weight.”
The team examined the short- and long-term effects of subcutaneous GIPFA-085 on measurable biological parameters such as blood glucose, food intake, body weight, respiratory exchange ratio, and plasma leptin levels in DIO mice. They also conducted similar experiments on ob/ob mice that were genetically programmed to exhibit leptin dysfunction. Leptin—a hormone synthesized by fat cells—controls satiety and energy storage by providing feedback to the central nervous system.
The administered GIPFA-085 doses were as low as 30 nmol/kg or as high as 300 nmol/kg during these murine experiments. The team found that a single dose (30–300 nmol/kg) of subcutaneously injected GIPFA-085 reduced blood glucose, elevated plasma leptin levels at 0.5–6 h, and inhibited food intake at 2–24 h in DIO mice. Dr. Yabe remarks, “A daily dose of GIPFA-085 (300 nmol/kg) not only inhibited food intake but also increased fat utilization on day 1, and reduced body weight gain on days 3–12 of the treatment. This observation was evident in DIO mice but not in ob/ob mice.”
In addition, the injected GIPFA-085 demonstrated the coordination of the satiety-signaling leptin with the murine central nervous system through the regulation of intracellular calcium concentration ([Ca2+]i). GIPFA-085 inhibited feeding and sustainedly lowered body weight in DIO mice via an increase in leptin and activation of the satiety neurons in the hypothalamic arcuate nucleus (ARC).
“GIPFA-085 increased [Ca2+]i in the ARC leptin-responsive and proopiomelanocortin (POMC) neurons. GIPFA-085 and leptin cooperated to increase [Ca2+]i in ARC neurons and inhibit food intake,” says Dr. Seino.
In summary, by demonstrating the therapeutic potential of GIPRAs in a mouse model, this study could facilitate the development of GIP/GLP-1 dual agonists to treat diabetes and obesity. The study also provides an avenue for novel incretin-GIP-based therapy.
“By demonstrating the therapeutic potential of GIPRAs, our study could lead to an increased quality of life in patients with diabetes and obesity. Our study also provides hope to several patients with obesity, who are suffering from a lack of safe and effective treatment for the disorder,” concludes Dr. Yada.
Reference
Authors
Wanxin Han1,2,3, Lei Wang1,2,3, Kento Ohbayashi4, Masakazu Takeuchi5, Libbey O’Farrell6, Tamer Coskun6, Yermek Rakhat1,2,3, Daisuke Yabe2,7,8, Yusaku Iwasaki4, Yutaka Seino7 and Toshihiko Yada1,2,3
Affiliations
1Center for Integrative Physiology, Kansai Electric Power Medical Research Institute, Kyoto 604-8436, Japan
2Department of Diabetes, Endocrinology and Metabolism/Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan
3Division of Diabetes, Metabolism and Endocrinology, Kobe University Graduate School of Medicine, Kobe 650-0047, Japan
4Laboratory of Animal Science, Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto 606-8522, Japan
5Eli Lilly Japan, Kobe 651-0086, Japan
6Eli Lilly Company, Indianapolis IN 46285, USA
7Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Hospital, Osaka 553-0003, Japan
8Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Gifu, Japan
END
The existing wildlife of a region is heavily shaped over generations by environmental factors and human activity. Activities like urbanization and hunting are known to reduce wildlife populations. However, some cultural or religious practices have, on occasion, preserved local animal populations. For instance, the forests around religious shrines in Japan have historically forbidden hunting and, as a consequence, provide refuge for certain animal species. A well-known example of this is the Japanese sika deer (Cervus nippon), which has historically been considered a holy creature.
A revered ...
Shoppers join food industry and health experts in backing UK plans to ban high fat, salt and sugar products from checkouts, store entrances and aisle ends
Consumers and retailers were asked about the impact of new government legislation aiming to restrict how unhealthy food is sold
Scientists behind investigation say ban can curb impulse buys that cause obesity – but warn of loopholes and limited resources that could undermine health benefits
A ban on selling junk foods from store entrances, aisle ends and checkouts should continue after a new study found the plans were largely backed by the British public and food industry.
Legislation ...
On 14 March, the European Platform for Neurodegenerative Diseases (EPND) launched its Cohort Catalogue. Featuring an extensive list of international cohorts across the neurodegenerative disease spectrum, the Cohort Catalogue is a central, open, accessible repository for researchers to discover ongoing studies and search metadata by disease area, biosample availability, imaging and cognitive data, and more.
The EPND consortium brings together experts in neurodegeneration research, data science, diagnosis and treatment from 29 public and private organisations. Funded by ...
Birmingham based charity, Help Harry Help Others and Aston University researchers, are working together to develop a pioneering pre-surgical diagnostic tool, which could see the eventual outcome of children with brain tumours drastically improve.
Help Harry Help Others, which became a registered charity in September 2012 and marked its 10th anniversary last year, was founded by Georgie Moseley, following the passing of her son Harry. Despite fighting an inoperable brain tumour, Harry raised over £750,000 for cancer research in the last two years of his life, before he passed away ...
Disposable plastics are everywhere: Food containers, coffee cups, plastic bags. Some of these plastics, called compostable plastics, can be engineered to biodegrade under controlled conditions. However, they often look identical to conventional plastics, get recycled incorrectly and, as a result, contaminate plastic waste streams and reduce recycling efficiency. Similarly, recyclable plastics are often mistaken for compostable ones, resulting in polluted compost.
Researchers at University College London (UCL) have published a paper in Frontiers ...
Electroluminescence is the production of light with an electrical current, without relying on heat or chemical reactions. This makes electroluminescent lights reliable and highly efficient: they are used as backlights in digital watches and in the displays of Apollo space shuttle guidance computers. Like OLEDs, light-emitting electrochemical cells (LECs)—which emit light through electroluminescence—have undergone many technological advancements. Close examination of the processes that lead to luminescence is essential ...
HOUSTON – (March 13, 2023) – Synthetic biologists at Rice University are embarking on a three-year project to create “genetically encoded antibiotics,” strands of RNA that bacteria will readily copy and share that will selectively kill only disease-causing, pathogenic bacteria.
“Most bacteria pose no danger to human health,” said James Chappell, an assistant professor of biosciences and bioengineering at Rice. “The question for us as synthetic biologists is, ‘Can we create genetic programs that move through microbial communities and precisely remove only the bad actors from those communities?’”
Thanks ...
One of the key factors of success in a dental implant is the condition of the periodontium around the implant. A higher long-term success rate of dental implants requires sufficient and healthy alveolar bone. In those cases where lack of alveolar bone renders setting an implant difficult, the bone should be regenerated sufficiently to receive the implant, whether before or during the implant surgery. Development of osteogenic barrier coating material for implants by a Korean research team is expected to improve the success rate of alveolar bone grafting.
Three research teams led by Professor Hyung Joon Cha of the Chemical Engineering ...
Scientists have documented plant species for centuries to help us understand and protect the incredible diversity of flora in our world. But according to new research, many have never actually been photographed in their natural habitats – and that’s a problem.
Researchers from UNSW Sydney and the Australian Institute of Botanical Science, part of the Royal Botanic Gardens and Domain Trust, surveyed 33 major online databases of plant photographs to examine the photographic record of Australian plant species. The findings, published in New Phytologist, reveal out of 21,077 native Australian vascular plant species, almost 20 per cent lack a verifiable photograph.
Lead ...
Patients-turned-social-media-influencers routinely offer prescription drug advice to their followers and often have close ties with pharmaceutical companies, according to new University of Colorado Boulder research.
But they also tend to have good intentions, the study found.
The study, published this week in the Journal of Medical Internet Research, provides some of the first insights into the burgeoning, loosely regulated world of so-called “patient influencers,” sharing findings from 26 in-depth interviews about why and how they do it.
“The bottom line here is that patient influencers act as a form ...
